Page last updated: 2024-09-05

dronedarone and Cardiovascular Diseases

dronedarone has been researched along with Cardiovascular Diseases in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's9 (64.29)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Bohn, RL; Bozzi, S; Goehring, EL; Jones, JK; Naccarelli, GV; Pezzullo, J; Sicignano, N; Tamayo, RCSG; Tave, AK1
Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ1
Badimon, JJ; Halperin, JL; Santos-Gallego, CG; Smith, DA; Zafar, MU1
Ariano, C; De Vecchis, R1
Leaver, L; Maruthappu, M; Wayne, RP; Young, C1
Amlie, J; Carlsen, J; Crijns, H; Gøtzsche, O; Køber, L; Lévy, S; McMurray, JJ; Torp-Pedersen, C1
Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M1
Floyd, J1
Duray, GZ; Hohnloser, SH; Schmitt, J1
Afzal, R; Alings, M; Amerena, J; Atar, D; Avezum, Á; Baret-Cormel, L; Blomström, P; Borggrefe, M; Budaj, A; Camm, AJ; Chen, SA; Ching, CK; Chrolavicius, S; Commerford, P; Connolly, SJ; Dans, A; Davy, JM; Delacrétaz, E; Di Pasquale, G; Diaz, R; Dorian, P; Flaker, G; Golitsyn, S; Gonzalez-Hermosillo, A; Granger, CB; Halperin, JL; Heidbüchel, H; Hohnloser, SH; Joyner, C; Kautzner, J; Kim, JS; Lanas, F; Lewis, BS; Merino, JL; Morillo, C; Murin, J; Narasimhan, C; Paolasso, E; Parkhomenko, A; Peters, NS; Sim, KH; Staiger, C; Stiles, MK; Tanomsup, S; Toivonen, L; Tomcsányi, J; Torp-Pedersen, C; Tse, HF; Vardas, P; Vinereanu, D; Weinling, E; Xavier, D; Yusuf, S; Zhu, J; Zhu, JR1
Boiangiu, C; Cohen, M1
Åkerborg, Ö; Bégo-Le Bagousse, G; Lindgren, P; Nilsson, J; Rosenquist, M1
Salam, AM1

Reviews

3 review(s) available for dronedarone and Cardiovascular Diseases

ArticleYear
Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs.
    Minerva cardioangiologica, 2019, Volume: 67, Issue:2

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Heart Failure; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Time Factors

2019
The management of patients with atrial fibrillation and dronedarone's place in therapy.
    Advances in therapy, 2011, Volume: 28, Issue:12

    Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Dronedarone; Heart Rate; Humans; Practice Guidelines as Topic; Risk Factors; Sex Factors

2011
Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Expert review of cardiovascular therapy, 2012, Volume: 10, Issue:11

    Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Monitoring; Early Termination of Clinical Trials; Humans; Randomized Controlled Trials as Topic; Risk Factors

2012

Trials

3 trial(s) available for dronedarone and Cardiovascular Diseases

ArticleYear
Increased mortality after dronedarone therapy for severe heart failure.
    The New England journal of medicine, 2008, Jun-19, Volume: 358, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Dronedarone; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Treatment Failure; Ventricular Dysfunction, Left

2008
Effect of dronedarone on cardiovascular events in atrial fibrillation.
    The New England journal of medicine, 2009, Feb-12, Volume: 360, Issue:7

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; Creatinine; Double-Blind Method; Dronedarone; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Secondary Prevention; Treatment Outcome

2009
Dronedarone in high-risk permanent atrial fibrillation.
    The New England journal of medicine, 2011, Dec-15, Volume: 365, Issue:24

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Chronic Disease; Digoxin; Double-Blind Method; Dronedarone; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Risk Factors; Stroke

2011

Other Studies

8 other study(ies) available for dronedarone and Cardiovascular Diseases

ArticleYear
Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
    The American journal of cardiology, 2020, 11-15, Volume: 135

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Cohort Studies; Dronedarone; Epidemiologic Studies; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Treatment Outcome

2020
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Rivaroxaban; Taiwan

2021
Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions.
    Atherosclerosis, 2017, Volume: 266

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Dronedarone; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests

2017
Reversible acute kidney injury requiring haemodialysis five days after starting dronedarone in a stable 71-year-old man at risk of cardiovascular polypharmacy.
    The journal of the Royal College of Physicians of Edinburgh, 2013, Volume: 43, Issue:2

    Topics: Acute Kidney Injury; Aged; Amiodarone; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Diseases; Dehydration; Diarrhea; Dronedarone; Humans; Hypotension; Male; Pharmacovigilance; Polypharmacy; Renal Dialysis

2013
Dronedarone in atrial fibrillation.
    The New England journal of medicine, 2009, Jun-04, Volume: 360, Issue:23

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Hospitalization; Humans; Secondary Prevention

2009
Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:4 Suppl

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Clinical Trials as Topic; Dronedarone; Humans

2010
Dronedarone trial stopped due to excess mortality.
    Prescrire international, 2011, Volume: 20, Issue:122

    Topics: Amiodarone; Atrial Fibrillation; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Dronedarone; Early Termination of Clinical Trials; Humans

2011
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2013, Volume: 14, Issue:3

    Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Cardiovascular Diseases; Cost-Benefit Analysis; Dronedarone; Europe; Health Status; Humans; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sex Factors; Survival Analysis

2013